By Justin Yamashita, MSc. Benchtop, site, CRO: three levels of basic and clinical research, explained without spin.
New here? Root to Rx runs three pieces a week, down from five as of this issue. I manage oncology clinical trials for a living and one of my studies is going into launch, so I cut the schedule from 5 tracks rather than the standards.
THE ROOT ROOM
Where the characters work through the week's evidence.
How the tracks work together: The Root Room is where you watch a bad move actually work on somebody, and where misinformation starts with our version of Black Box Warnings. It shows you how to stay in the room and have a hard health conversation, using the same evidence Plain Talk breaks down and The Informed sources.
Last week Marisol found the freezer bank where 230,000 plant extracts sit waiting for somebody to finish the job of turning one into a medicine. This week we go one stop further up the pipeline, before any of that reaches an animal, a person, or a freezer at all.
Zoe's Living Room, and Then a Kitchen
"Turn it off," Iris says, and doesn't say anything else for a second.
Two kids, a borrowed phone, and a video built to be shared rather than checked.
Zoe's older brother left his phone propped against the cereal box before he wandered off, paused mid-scroll, and it landed between them somewhere in the middle of cartoons. A slick video, a dog behind bars, wide-eyed. A voice saying the people who make your medicine don't care what it costs an animal to get there.
Domino, curled under the coffee table at Iris's feet, sits up.
"It's just a video," Zoe says, reaching for the phone.
"Wait." Iris doesn't look away from the frozen frame. "Is that true?"
Zoe shrugs. "I don't know. It has like 4 million views."
"That's not the same thing," Iris says, quiet, mostly to herself.
Nobody answers her from standing.
That evening Iris walks into the kitchen where Sam the Skeptic is drying dishes and Rooty the Researcher is buried in a new science article.
"This doesn't feel right, and I don't like how this makes me feel. Was the dog real?" she asks.
Cora crouches next to her, one hand on Domino, who followed Iris in and has pressed himself against her shin.
"Hold on," Cora says, to the room more than to Iris. "Before anybody answers her, are we helping her, or are we winning?"
Sam puts the towel down.
"Probably," Sam says. "That doesn't mean the story around it was."
Auntie Nani arrives for dinner with some sushi, sets it down, and crouches to Iris's height instead of answering from standing.
"You looked scared just saying it," Nani says.
"I love animals," Iris says, like it's a confession. "More than almost anything and I don't want them to be tested on."
"Good," Nani says. "That's not the part anybody should talk you out of."
Rooty sets his reading down. He pulls a clear chip the size of a USB drive out of his bag and holds it up to the kitchen light. A friend of his built it and sent it over to see what he thought, along with the paper he has been buried in all evening.
"Iris, check this little chip out. This isn't an animal," he says. "It's not a petri dish of one kind of cell either. It's got human liver cells living in channels the width of a hair, with fluid moving through it the way blood would. We can watch what a new medicine might do to a human liver before it goes anywhere near a person."
"So you don't need the animals?" Iris asks.
"Less than we used to. And it keeps getting truer every year, not because anyone decided animals stopped mattering, but because for a long time this technology didn't exist to check with instead." Rooty sets the chip on the counter, carefully. "There's a real reason people leaned on animal testing so long. It used to be the best guess anyone had for what a drug would do in a human body. The problem is it was always a guess, made by a stand-in for the body the medicine was actually written for."
Nani leans against the counter.
"And a guess is still a guess even when it's a good one," she says. "More than 90% of the drugs that pass in animals still fail once they reach an actual human, mostly because they turn out unsafe, or they just don't work the way the animal data promised."
Iris frowns at the number. "90?!"
"Out of every hundred," Nani says. "That's not the animals lying to anyone. It's the translation. A mouse liver and a human liver don't always behave the same, and until recently nobody had a good way to ask the human question directly, this early."
"So this," Iris says slowly, looking at the chip, "asks the human question?"
Rooty looks at Nani, then at Sam. "There's a place I could show her. My friend's lab. It used to be an animal facility, and half of it isn't anymore."
"Saturday," Nani says, and it isn't a question.
Black Box Warning
Tactic: The House Always Gets Its Cut
Tool: profiting off the argument itself, never off either side winning it
Running it: you have never seen him, only his employees
The Broker, the mastermind behind the bad actors and the bad acts, the one creating the misinformation biome.
You've met his people already, even if nobody told you they worked the same desk. Naturella, warm and sincere, selling safety by origin. Influencer Ivy, selling her reputation and lifestyle instead of a source. Bias the Brain, just nodding at what you already felt playing with your confirmation bias. None of them coordinate, and none of them need to.
What they have in common is who cashes out when they win, and it is not primarily them. Doubt is the product, and whoever runs the desk gets paid on volume, not on being right. A video like the one on Zoe's brother's phone doesn't need to be true to work. It only needs to get watched, argued about, and shared, and someone takes a cut of all three whether the dog in the cage is real or not.
The leader of this motley crew is never in the room himself. A ledger, a bank of screens, a gloved hand adjusting a dial, nothing more than that, because a business built on funding both sides of an argument does not survive being looked at directly.
He has exactly one weakness, and it's not a sharper argument. It's a room that checks together instead of a person who checks alone. One skeptic he can outlast for years. A crowd of them, comparing notes before they share anything, he cannot afford. Nobody defeats him in one issue, or ever. He gets starved, slowly, by numbers.
He is fiction, and so are the people who work for him. They dramatize tactics, never a real person, company, platform or agency. Name the move, not the neighbor.
The Room: The Preclinical Lab, Half Changed Over
A chip the size of a USB drive, with human liver cells living in channels the width of a hair.
The lab turns out to be one long room with the benches down the middle, and half of it still labeled for a job it doesn't do here anymore. Rooty's friend finds Iris a step stool. Domino, who was not strictly invited, settles under it.
Rooty sets the chip on the bench, under a monitor showing something magnified and pink.
"This chip asks the human question," Rooty says. "So does that dish in the fridge behind you, an organoid, a little cluster of human cells grown to behave like a miniature organ. So does the laptop in the other room. Some of this gets run in software first, on models trained on real human data, before anything touches a single cell." He turns the chip so the light catches it. "Congress changed the law back in 2022. A company doesn't have to test on animals before it tests on people anymore. They still can, and sometimes they still should. It just stopped being required."
"Then why do they still do it at all?" Iris asks, and it isn't an accusation, it's the actual question.
"Because we're not finished switching, and pretending we are would be its own kind of lie," Nani says. "The agency that has to carry that law out is on record saying it wants animal studies to be the exception instead of the norm within a few years, not right now. And there's already real ground gained, not just a promise. Testing that used to need blood from a horseshoe crab is being phased out, and that alone could spare more than a million animals a year. But it's not a light switch. It's a slow one, and it's slow because it has to be done right, not because nobody's trying."
"Wait, the horseshoe crabs?" Iris says. "I get to touch those at the Mote Aquarium. The volunteers let you hold your hand flat and they walk right over it."
She looks back at the chip. "So the video was wrong?"
"The video wanted you sure of something simple," Sam says. "That's usually the tell. This," he nods at the chip, "is not simple, and it's not finished, and both of those are true at the same time."
Domino puts his chin on the step stool. Iris scratches behind his ear without looking away from the chip.
"I still want there to be less," she says.
"So does everyone standing in this room," Nani says. "That's not naive of you. That's the direction this is actually heading. You're standing in the part that already changed."
The move to keep
You don't beat a business built on doubt by winning one argument with it. You starve it, and starving takes numbers, not a hero. Every person who checks before sharing, asks before believing, and brings someone else along to look, is one fewer customer at his desk. That's not a fight. That's just attendance.
Next issue: Diversity and Inclusion Criteria, and the room where a sponsor decides who a trial gets built to reach in the first place.
Send this to someone who needed it
Send this to someone whose kid loves animals too, and needs the honest version, not the comfortable one.
This week's Plain Talk takes the 90% apart: where the number comes from, why a stand-in was the best anyone had for decades, and how you tell a partial picture from a whole one.
You just watched a 7-year-old ask the same question your gut asks. Send this to someone who's been avoiding it, and collect a Series 1 card while you're at it.
Want the full science? Thursday's Informed covers the FDA's actual roadmap, the 90% number in full, and what's already been phased out versus what's still years away.
Thursday's The Informed doesn't arrive on its own. It's the same week's story with the receipts attached: every figure sourced, every citation ranked by how much weight it can actually hold, and the questions I couldn't close listed as open rather than quietly dropped. A full evidence dossier every week isn't what everyone signed up for, so it's opt-in rather than automatic. If you want it, click Manage preferences at the bottom of this email, sign in with your address, and tick The Informed (Thursdays). Ten seconds, it saves on its own, and you can switch it back off the same way.
New here? Root to Rx runs three pieces a week. Monday you watch a real health claim try to work on someone. Wednesday you get the tools to run it yourself. Thursday you get the full evidence so you can check my work. A LinkedIn-only special newsletter is coming soon as well called, The Roots. For any healthcare or clinical research or patient advocacy professionals who have had these talks and haven't gotten through, this is for you. Written by a clinical researcher, free, at RootToRx.com.
For educational purposes only. Nothing in this newsletter is medical advice. Talk to your doctor before making any health decision.
Instagram: instagram.com/roottorx | LinkedIn: linkedin.com/company/roottorx | Facebook Lab: facebook.com/groups/theroottorxlab | Subscribe: RootToRx.com
You are receiving this because you subscribed at roottorx.com.
Disclosure: Root to Rx is published independently by Open Label Media LLC. Views expressed are personal views of Justin Yamashita and do not represent his employer or any affiliated organization. No employer resources or proprietary information are used. Every claim is sourced from publicly available materials.
Root to Rx | 228 Park Ave S, #29976, New York, New York 10003, United States